Ecron Acunova-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ecron Acunova - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013182
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ecron Acunova (EA), a subsidiary of Take Solutions Ltd. is a clinical research organization (CRO) serving big pharma companies locally. It offers clinical trial management, clinical data management services. Its services include bioavailability and bioequivalence services, Phase I to IV clinical trials, peri approval studies, PMS, rescue studies, clinical data management and biostatistics, medical writing, regulatory affairs, pharmacovigilance, and central laboratory. Ecron provides bioavailability and bioequivalence services such as consulting, IP import and sample export, protocol design, ethics committee submissions, safety screening and bio analytical testing. The company serves pharmaceutical, biotechnology, nutritional, device and medical diagnostics industries. It operates in South East Asia, Central and Nordic Europe and North America. Ecron Acunova is headquartered in Bangalore, Karnataka, India.

Ecron Acunova – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ecron Acunova, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Manipal Acunova Plans To Raise Up To US$30 Million In Venture Financing 11
Partnerships 12
Ecron Acunova Forms Joint venture With Jamjuree Innovations 12
Acquisition 13
TAKE Solutions to Acquire Ecron Acunova 13
Ecron Acunova Acquires Majority Stake In aCROnordic 14
Ecron Acunova – Key Competitors 15
Ecron Acunova – Key Employees 16
Ecron Acunova – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 18
Recent Developments 19
Other Significant Developments 19
Jun 09, 2017: Ecron Acunova to offer end-to-end capabilities as ‘Navitas Life Sciences 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Ecron Acunova, Pharmaceuticals & Healthcare, Key Facts 2
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Manipal Acunova Plans To Raise Up To US$30 Million In Venture Financing 11
Ecron Acunova Forms Joint venture With Jamjuree Innovations 12
TAKE Solutions to Acquire Ecron Acunova 13
Ecron Acunova Acquires Majority Stake In aCROnordic 14
Ecron Acunova, Key Competitors 15
Ecron Acunova, Key Employees 16
Ecron Acunova, Other Locations 17
Ecron Acunova, Subsidiaries 17
Ecron Acunova, Joint Venture 18

★海外企業調査レポート[Ecron Acunova-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stamps com Inc (STMP):企業の財務・戦略的SWOT分析
    Stamps com Inc (STMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Orkuveita Reykjavikur-エネルギー分野:企業M&A・提携分析
    Summary Orkuveita Reykjavikur (Orkuveita) is a public utility company that provides electricity and water. The company generates and supplies electricity. It harnesses hot water from geothermal fields and supplies it for heating applications. The company also supplies cold water from its groundwater …
  • Baker Hughes, a GE Co LLC (BHGE):石油・ガス:M&Aディール及び事業提携情報
    Summary Baker Hughes, a GE Co LLC (BHGE), formerly Baker Hughes Inc, a subsidiary of General Electric Co is a provider of oil and gas equipment and services. Its portfolio includes drilling equipment, subsea production systems, pipe systems, compressors, electric generators, energy recovery and stor …
  • Pacific Hydro Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary Pacific Hydro Pty Ltd (Pacific Hydro), a subsidiary of State Power Investment Corporation is an energy solutions provider that undertakes the development and operations of the renewable power projects. The company offers wind, hydro, solar and geothermal power projects at varying stages of d …
  • Masterflex SE (MZX):企業の財務・戦略的SWOT分析
    Summary Masterflex SE (Masterflex), formerly Masterflex AG, is a manufacturer and supplier of spiral hoses. The company manufactures and markets high-tech spiral hoses. It offers hoses and connecting systems such as abrasion-resistant suction and transport hoses made from PU, suction and transport h …
  • Central Glass Co Ltd (4044):企業の財務・戦略的SWOT分析
    Central Glass Co Ltd (4044) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tauron Polska Energia SA:企業の発電所・SWOT分析2018
    Tauron Polska Energia SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務情報
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Equifax Inc.:企業の戦略・SWOT・財務情報
    Equifax Inc. - Strategy, SWOT and Corporate Finance Report Summary Equifax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Tokmanni Group Oyj (TOKMAN):企業の財務・戦略的SWOT分析
    Tokmanni Group Oyj (TOKMAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • MSC Industrial Direct Co Inc (MSM):企業の財務・戦略的SWOT分析
    MSC Industrial Direct Co Inc (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Jubilee General Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • EDF Renewable Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. The company designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It …
  • ORBIT Communication Systems Ltd:企業の戦略・SWOT・財務分析
    ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • Ascena Retail Group, Inc.:企業の戦略・SWOT・財務分析
    Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Wageningen University-製薬・医療分野:企業M&A・提携分析
    Summary Wageningen University (WU), a subsidiary of Wageningen University and Research Centre, is an education and research institution. The university offers bachelors’, masters’ and PhD programs. It specializes in healthy food and living environment domain. WU offers various courses in bachelor of …
  • PTC KAMAZ:企業のM&A・事業提携・投資動向
    PTC KAMAZ - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PTC KAMAZ Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Peptimimesis SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptimimesis SAS (Peptimimesis) is a biopharmaceutical company that discovers and develops transmembrane therapeutic peptides. The company’s proprietary platform delivers a set of drug candidates that act on strategic targets in the field of immuno-oncology, oncology and immune diseases. Its …
  • CureMeta LLC-製薬・医療分野:企業M&A・提携分析
    Summary CureMeta LLC (CureMeta) is a biotechnology company that concentrates on the development of immunology therapeutics for cancers. The company advances novel antibody drug conjugates targeting pluripotent stem cells. Its pipeline product comprises Bstrongximab-ADC. CureMeta develops the antibod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆